Over the past weeks, attention has shifted from COVID-19 to the unnecessary death of George Floyd, along with the subsequent protests around the world that have spread in reaction to a sad example of injustice.
Our mission drives us to empower people to connect with others; however, this connection is only of value when there is mutual respect. The behaviours and values that are promoted throughout Cochlear require us to raise difficult and important issues. Race inequality is certainly a topic we must raise and talk about together.
Many people cannot imagine the reality some of our co-workers, customers and friends have experienced because of their race. But we need to try.
There is no place for hate, intolerance, divisiveness or racism at Cochlear.
As an organisation, we strive to support a community that champions equality, diversity and respect for the dignity and humanity of everyone. We are not perfect. We can do better. We don’t have all the ideas or all the answers. But we will listen. The responsibility for making our world a safer, more accepting and more inclusive place starts with each of us. We can make a difference. We have to.
CEO & President, Cochlear
Please seek advice from your health professional about treatments for hearing loss. Outcomes may vary, and your health professional will advise you about the factors which could affect your outcome. Always follow the directions for use. Not all products are available in all countries. Please contact your local Cochlear representative for product information.
In Australia, Cochlear™ Nucleus® implant systems are intended for the treatment of moderately severe to profound hearing loss.
In Australia, Baha® bone conduction implant systems are intended for the treatment of moderate to profound hearing loss.
In Australia, the Cochlear™ Osia® System is indicated for patients with conductive, mixed hearing loss and single-sided sensorineural deafness (SSD) aged 10 years and above with up to 55 decibels sensorineural hearing loss. Patients should have sufficient bone quality and quantity to support successful implant placement. Surgery is required to use this product. Any surgical procedure carries risk.
For Cochlear™ Nucleus®, Osia® and Baha® systems: This product is not available for purchase by the general public. For information on funding and reimbursement please contact your health care professional.
Any testimonial featured on this website is intended for an Australian audience only.